EU regulatory panel backs Moderna’s updated COVID shot, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

The updated shot, branded Spikevax, to target the dominant XBB.1.5 variant of Omicron was recommended for use in adults and children aged 6 months and above. Earlier this month, the European Commission authorised an updated COVID-19 vaccine from Pfizer and its German partner BioNtech for the same population., The updated shot, branded Spikevax, to target the dominant XBB.1.5 variant of Omicron was recommended for use in adults and children aged 6 months and above. Earlier this month, the European Commission authorised an updated COVID-19 vaccine from Pfizer and its German partner BioNtech for the same population., , Read More